Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients.
暂无分享,去创建一个
[1] J. I. Arenas Miravé,et al. [Infectious esophagitis]. , 1999, Gastroenterology & hepatology.
[2] C. Wilcox,et al. Esophageal infections: etiology, diagnosis, and management. , 1994, The Gastroenterologist.
[3] D. Greenspan,et al. Treatment of oropharyngeal candidiasis in HIV-positive patients. , 1994, Journal of the American Academy of Dermatology.
[4] L. Laine,et al. Esophageal disease in human immunodeficiency virus infection. , 1994, Archives of internal medicine.
[5] D. Greenspan,et al. Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group. , 1993, Journal of acquired immune deficiency syndromes.
[6] T. Berger. Treatment of bacterial, fungal, and parasitic infections in the HIV-infected host. , 1993, Seminars in dermatology.
[7] E. Scapa,et al. [Gastrointestinal manifestations in AIDS]. , 1993, Harefuah.
[8] A. Glatt. Therapy for oropharyngeal candidiasis in HIV-infected patients. , 1993, Journal of Acquired Immune Deficiency Syndromes.
[9] M. Khamashta,et al. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. , 1992, The American journal of gastroenterology.
[10] L. Laine,et al. Fluconazole Compared with Ketoconazole for the Treatment of Candida Esophagitis in AIDS , 1992, Annals of Internal Medicine.
[11] M. Khamashta,et al. [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes]. , 1992, Medicina clínica (Ed. impresa).
[12] P. Piot,et al. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. , 1992, Annales de la Societe belge de medecine tropicale.
[13] A. Lazzarin,et al. Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. , 1991, The American journal of gastroenterology.
[14] B. Gazzard,et al. Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. , 1991, AIDS.
[15] T. Young,et al. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. , 1991, Archives of internal medicine.
[16] R. Colebunders,et al. Natural history and clinical presentation of HIV-1 infection in adults. , 1991, AIDS.
[17] B. Gazzard,et al. Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome. , 1989, Gut.
[18] W. Nkya,et al. Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. , 1989, AIDS.
[19] H. Goossens,et al. COMPARISON OF FLUCONAZOLE AND KETOCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN AIDS , 1989, The Lancet.
[20] M. Cernuschi,et al. The diagnosis of esophageal candidiasis in patients with acquired immune deficiency syndrome: is endoscopy always necessary? , 1989, The American journal of gastroenterology.
[21] K. D. de Cock. Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. , 1989, World Health Organization AIDS technical bulletin.
[22] J. Raufman,et al. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.
[23] J. Aronson,et al. Oxford Textbook of Clinical Pharmacology and Drug Therapy , 1985 .
[24] R. Holt,et al. MICONAZOLE-RESISTANT CANDIDA , 1978, The Lancet.
[25] K. Iswara,et al. Candida esophagitis: a prospective study of 27 cases. , 1976, Gastroenterology.
[26] H. Shwachman,et al. Letter: Screening for cystic fibrosis. , 1976, Lancet.